Premium
5q31.3 Microdeletion syndrome: Clinical and molecular characterization of two further cases
Author(s) -
Brown Natasha,
Burgess Trent,
Forbes Robin,
McGillivray George,
Kornberg Andrew,
Mandelstam Simone,
Stark Zornitza
Publication year - 2013
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.36108
Subject(s) - haploinsufficiency , microdeletion syndrome , genetics , phenotype , hypotonia , biology , intellectual disability , gene , medicine
The 5q31.3 microdeletion syndrome has recently emerged as a distinct clinical entity, and we report two new patients with de novo deletions of this region, bringing the total to seven. Similarly to previously reported cases, the phenotype of our patients is characterized by marked hypotonia, apnea, developmental delay, and feeding difficulties. Both patients had abnormal movements which did not correlate with epileptiform activity on electroencephalogram (EEG). Developmental brain changes on neuroimaging consisted of abnormalities predominantly affecting the white matter and frontal lobes. The 5q31.3 deleted regions overlap those of previously reported cases, and allow further refinement of the shortest region of overlap to 101 kb, including only three genes. Of these, the purine‐rich element binding protein A ( PURA ) gene has an established role in brain development, and we propose that haploinsufficiency for this gene is primarily responsible for the neurodevelopmental features observed. © 2013 Wiley Periodicals, Inc.